Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 9—September 2009
Research

Clinical Assessment and Improved Diagnosis of Bocavirus-induced Wheezing in Children, Finland

Maria Söderlund-VenermoComments to Author , Anne Lahtinen, Tuomas Jartti, Lea Hedman, Kaisa Kemppainen, Pasi Lehtinen, Tobias Allander, Olli Ruuskanen, and Klaus Hedman
Author affiliations: University of Helsinki, Helsinki, Finland (M. Söderlund-Venermo, A. Lahtinen, L. Hedman, K. Kemppainen, K. Hedman); Helsinki University Central Hospital, Helsinki (L. Hedman, K. Hedman) Turku University Hospital, Turku, Finland (T. Jartti, P. Lehtinen, O. Ruuskanen); Karolinska Institute, Stockholm, Sweden (T. Allander); Karolinska University Hospital, Stockholm (T. Allander)

Main Article

Table 1

Human bocavirus EIA and quantitative PCR results for 258 wheezing children, Finland*

PCR result No. children Serodiagnoses, IgM+,† no (%)
 No serodiagnoses, no. (%)
SDG SC SI IgG+ IgG– All IgG+ IgG– Maternal
NPA+ serum+ 34 33 (97) 21 4 6 2 1 0 1 0
NPA+ serum– 15 2 (13) 0 0 2 0 13 10 3 0
NPA– serum– 194 1† (0.5) 1† 0 0 0 193 100 88 5
NPA– serum+ 15 12 (80) 6 1 2 3 3 1 2 0
NPA+ 49 35 (71) 21 4 8 2 14 10 4 0
NPA+, high load 28 27 (96) 21 3 2 1 1 0 1 0
NPA+, low load 21 8 (38) 0 1 6 1 13 10 3 0
Serum+ 49 45 (92) 27 5 8 5 4 1 3 0
NPA– 209 13 (6) 7† 1 2 3 196 101 90 5
Serum– 209 3 (1.4) 1† 0 2 0 206 110 91 5
Any PCR+
 64
 47 (73)
 27
 5
 10
 5
17
 11
 6
 0
Total 258‡ 48 (19) 28 5 10 5 210 111 94 5

*EIA, enzyme immunoassay; Ig, immunoglobulin; serodiagnoses (SDG), IgM positive and/or IgG conversion or increase; no serodiagnoses, IgM negative and no seroconversion/increase; SC, seroconversion; SI, serologic increase (>-fold increase in IgG); IgG+, constant level (<4-fold increase) of IgG in paired serum samples; IgG–, IgG negative in both serum samples; NPA, nasopharyngeal aspirate; Serum+, PCR positive in either or both serum samples.
†One child was IgM negative. The IgG value of the convalescent-phase serum sample barely exceeded the cutoff value and the child was considered as not having an acute human bocavirus infection.
‡One of 259 children (10) was not included in this comparison because of depletion of the convalescent-phase serum sample before the PCR (NPA and acute-phase serum samples were PCR negative; both serum samples were IgG positive and IgM negative, indicating immunity).

Main Article

References
  1. Allander  T, Tammi  MT, Eriksson  M, Bjerkner  A, Tiveljung-Lindell  A, Andersson  B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A. 2005;102:12891–6. DOIPubMedGoogle Scholar
  2. Schildgen  O, Müller  A, Allander  T, Mackay  IM, Völz  S, Kupfer  B, Human bocavirus: passenger or pathogen in acute respiratory tract infections? Clin Microbiol Rev. 2008;21:291–304. DOIPubMedGoogle Scholar
  3. Choi  EH, Lee  HJ, Kim  SJ, Eun  BW, Kim  NH, Lee  JA, The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000–2005. Clin Infect Dis. 2006;43:585–92. DOIPubMedGoogle Scholar
  4. Cilla  G, Oñate  E, Perez-Yarza  E, Montes  M, Vicente  D, Perez-Trallero  E. Viruses in community-acquired pneumonia in children aged less than 3 years old: high rate of viral coinfection. J Med Virol. 2008;80:1843–9. DOIPubMedGoogle Scholar
  5. Fry  AM, Lu  X, Chittaganpitch  M, Peret  T, Fischer  J, Dowell  SF, Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand. J Infect Dis. 2007;195:1038–45. DOIPubMedGoogle Scholar
  6. Kesebir  D, Vazquez  M, Weibel  C, Shapiro  ED, Ferguson  D, Landry  ML, Human bocavirus infection in young children in the United States: molecular epidemiological profile and clinical characteristics of a newly emerging respiratory virus. J Infect Dis. 2006;194:1276–82. DOIPubMedGoogle Scholar
  7. Lahti  E, Peltola  V, Waris  M, Virkki  R, Rantakokko-Jalava  J, Eerola  E, Induced sputum in the diagnosis of childhood community-acquired pneumonia. Thorax. 2009;64:252–7. DOIPubMedGoogle Scholar
  8. Manning  A, Russell  V, Eastick  K, Leadbetter  GH, Hallam  N, Templeton  K, Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis. 2006;194:1283–90. DOIPubMedGoogle Scholar
  9. von Linstow  ML, Høgh  M, Høgh  B. Clinical and epidemiologic characteristics of human bocavirus in Danish infants: results from a prospective birth cohort study. Pediatr Infect Dis J. 2008;27:897–902. DOIPubMedGoogle Scholar
  10. Allander  T, Jartti  T, Gupta  S, Niesters  HG, Lehtinen  P, Osterback  R, Human bocavirus and acute wheezing in children. Clin Infect Dis. 2007;44:904–10. DOIPubMedGoogle Scholar
  11. Kantola  K, Hedman  L, Allander  T, Jartti  T, Lehtinen  O, Ruuskanen  O, Serodiagnosis of human bocavirus infections. Clin Infect Dis. 2008;46:540–6. DOIPubMedGoogle Scholar
  12. Endo  R, Ishiguro  N, Kikuta  H, Teramoto  S, Shirkoohi  R, Ma  X, Seroepidemiology of human bocavirus in Hokkaido Prefecture, Japan. J Clin Microbiol. 2007;45:3218–23. DOIPubMedGoogle Scholar
  13. Kahn  JS, Kesebir  D, Cotmore  S, D’Abramo  A Jr, Cosby  C, Weibel  C, Seroepidemiology of human bocavirus defined using recombinant virus-like particles. J Infect Dis. 2008;198:41–50. DOIPubMedGoogle Scholar
  14. Lin  F, Guan  W, Cheng  F, Yang  N, Pintel  D, Qiu  J. ELISAs using human bocavirus VP2 virus-like particles for detection of antibodies against HBoV. J Virol Methods. 2008;149:110–7. DOIPubMedGoogle Scholar
  15. Lindner  J, Karalar  L, Zehentmeier  S, Plentz  AS, Pfister  H, Struff  W, Humoral immune response against human bocavirus VP2 virus-like particles. Viral Immunol. 2008;21:443–9. DOIPubMedGoogle Scholar
  16. Jartti  T, Lehtinen  P, Vuorinen  T, Osterback  R, van den Hoogen  B, Osterhaus  AD, Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis. 2004;10:1095–101.PubMedGoogle Scholar
  17. Ekman  A, Hokynar  K, Kakkola  L, Kantola  K, Hedman  L, Bondén  H, Biological and immunological relations of human parvovirus B19 genotypes 1–3. J Virol. 2007;81:6927–35. DOIPubMedGoogle Scholar
  18. Kaikkonen  L, Lankinen  H, Harjunpää  I, Hokynar  K, Söderlund-Venetmo  M, Oker-Blom  C, Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection. J Clin Microbiol. 1999;37:3952–6.PubMedGoogle Scholar
  19. Kallio-Kokko  H, Vapalahti  O, Lundkvist  Å, Vaheri  A. Evaluation of Puumala virus IgG and IgM enzyme immunoassays based on recombinant baculovirus-expressed nucleocapsid protein for early nephropathia epidemica diagnosis. Clin Diagn Virol. 1998;10:83–90. DOIPubMedGoogle Scholar
  20. Söderlund  M, Brown  CS, Spaan  WJ, Hedman  L, Hedman  K. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis. 1995;172:1431–6.PubMedGoogle Scholar
  21. National Asthma Education and Prevention Program. Expert Panel Report 3. Guidelines for the diagnosis and management of asthma. Bethesda (MD): National Heart, Lung, and Blood Institute; 2007.
  22. Corcoran  A, Mahon  BP, Doyle  S. B cell memory is directed toward conformational epitopes of parvovirus B19 capsid proteins and the unique region of VP1. J Infect Dis. 2004;189:1873–80. DOIPubMedGoogle Scholar
  23. Enders  M, Schalasta  G, Baisch  C, Weidner  A, Pukkila  L, Kaikkonen  L, Human parvovirus B19 infection during pregnancy: value of modern molecular and serological diagnostics. J Clin Virol. 2006;35:400–6. DOIPubMedGoogle Scholar
  24. Arden  KE, McErlean  P, Nissen  MD, Sloots  TP, Mackay  IM. Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections. J Med Virol. 2006;78:1232–40. DOIPubMedGoogle Scholar
  25. Arnold  JC, Singh  KK, Spector  SA, Sawyer  MH. Human bocavirus: prevalence and clinical spectrum at a children's hospital. Clin Infect Dis. 2006;43:283–8. DOIPubMedGoogle Scholar
  26. Ma  X, Endo  R, Ishiguro  N, Ebihara  T, Ishiko  H, Ariga  T, Detection of human bocavirus in Japanese children with lower respiratory tract infections. J Clin Microbiol. 2006;44:1132–4. DOIPubMedGoogle Scholar
  27. Qu  XW, Duan  ZJ, Qi  ZY, Xie  ZP, Gao  HC, Liu  WP, Human bocavirus infection, People’s Republic of China. Emerg Infect Dis. 2007;13:165–8. DOIPubMedGoogle Scholar
  28. Sloots  TP, McErlean  P, Speicher  DJ, Arden  KE, Nissen  MD, Mackay  IM. Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J Clin Virol. 2006;35:99–102. DOIPubMedGoogle Scholar
  29. Smuts  H, Hardie  D. Human bocavirus in hospitalized children, South Africa. Emerg Infect Dis. 2006;12:1457–8.PubMedGoogle Scholar
  30. Weissbrich  B, Neske  F, Schubert  J, Tollmann  F, Blath  K, Blessing  K, Frequent detection of bocavirus DNA in German children with respiratory tract infections. BMC Infect Dis. 2006;6:109. DOIPubMedGoogle Scholar
  31. Gerna  G, Piralla  A, Campanini  G, Marchi  A, Stronati  M, Rovida  F. The human bocavirus role in acute respiratory tract infections of pediatric patients as defined by viral load quantification. New Microbiol. 2007;30:383–92.PubMedGoogle Scholar
  32. Jacques  J, Moret  H, Renois  F, Léveque  N, Motte  J, Andréoletti  L. Human bocavirus quantitative DNA detection in French children hospitalized for acute bronchiolitis. J Clin Virol. 2008;43:142–7. DOIPubMedGoogle Scholar
  33. Brieu  N, Guyon  G, Rodiére  M, Segondy  M, Foulongne  V. Human bocavirus infection in children with respiratory tract disease. Pediatr Infect Dis J. 2008;27:969–73. DOIPubMedGoogle Scholar
  34. Jackson  DJ, Gangnon  RE, Evans  MD, Roberg  KA, Anderson  EL, Pappas  TE, Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008;178:667–72. DOIPubMedGoogle Scholar
  35. Kotaniemi-Syrjänen  A, Vainionpää  R, Reijonen  T, Waris  M, Korhonen  K, Korppi  M. Rhinovirus-induced wheezing in infancy: the first sign of childhood asthma? J Allergy Clin Immunol. 2003;111:66–71. DOIPubMedGoogle Scholar
  36. Lehtinen  P, Ruohola  A, Vanto  T, Vuorinen  T, Ruuskanen  O, Jartti  T. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J Allergy Clin Immunol. 2007;119:570–5. DOIPubMedGoogle Scholar
  37. Papadopoulos  NG, Tsolia  M, Bossios  A, Astra  E, Prezerakou  A, Gourgiotis  D, Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med. 2002;165:1285–9. DOIPubMedGoogle Scholar
  38. Rakes  GP, Arruda  E, Ingram  J, Hoover  GE, Zambrano  JC, Hayden  FG, Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med. 1999;159:785–90.PubMedGoogle Scholar
  39. Richard  N, Komurian-Pradel  F, Javouhey  E, Perret  M, Rajoharison  A, Bagnaud  A, The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr Infect Dis J. 2008;27:213–7. DOIPubMedGoogle Scholar
  40. Alper  CM, Winther  B, Mandel  E, Hendley  J, Doyle  W. Rate of concurrent otitis media in upper respiratory tract infections with specific viruses. Arch Otolaryngol Head Neck Surg. 2009;135:17–21. DOIPubMedGoogle Scholar

Main Article

Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external